https://orcid.org/0000-0003-3916-4443
References
- Kazmers NH, Qiu Y, Yoo M, et al. The minimal clinically important difference of the PROMIS and QuickDASH instruments in a nonshoulder hand and upper extremity patient population. J Hand Surg Am. 2020;45(5):399–407.e6.
- Gómez Herrero D, Sanjuan-Cerveró R, Vazquez-Ferreiro P, et al. Patient reported outcome measures assessing health-related quality of life in Dupuytren’s disease: a systematic review. Int J Innov Res Med Sci. 2020;5(01):16–25.
- Bradet-Levesque I, Audet J, Roy JS, et al. Measuring functional outcome in dupuytren’s disease: a systematic review of patient-reported outcome measures. J Hand Ther. 2021.
- Rodrigues JN, Mabvuure NT, Nikkhah D, et al. Minimal important changes and differences in elective hand surgery. J Hand Surg Eur Vol. 2015;40(9):900–912.
- Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14:131.
- Beaudreuil J, Allard A, Zerkak D, et al. Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren’s disease-specific disability. Arthritis Care Res. 2011;63(10):1448–1455.
- Mohan A, Vadher J, Ismail H, et al. The Southampton Dupuytren’s Scoring Scheme. J Plast Surg Hand Surg. 2014;48(1):28–33.
- Bendixen LL, Jorgensen RW, Jensen CH. A patient-reported outcome measure for patients with Dupuytren’s disease. Dan Med J. 2020;67(6):A03190190.
- Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35.
- Smith-Forbes EV, Howell DM, Willoughby J, et al. Specificity of the minimal clinically important difference of the quick disabilities of the arm shoulder and hand (QDASH) for distal upper extremity conditions. J Hand Ther. 2016. 29(1):81–88. quiz 8.
- Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: is there a connection? J Biopharm Stat. 2004;14(1):97–110.
- Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109.
- Fletcher J, Tan ESL, Thomas M, et al. Collagenase injections for Dupuytren’s contracture: prospective cohort study in a public health setting. ANZ J Surg. 2019;89(5):573–577.
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415.
- Rodrigues JN, Zhang W, Scammell BE, et al. Recovery, responsiveness and interpretability of patient-reported outcome measures after surgery for Dupuytren’s disease. J Hand Surg Eur Vol. 2017;42(3):301–309.
- Turner D, Schünemann HJ, Griffith LE, et al. Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. J Clin Epidemiol. 2009;62(4):374–379.